Zoetis Inc. announced that on February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at the Company, for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company. Mr. David's conduct did not impact the consolidated financial statements or internal controls over financial reporting. As a result of Mr. David's termination, he is not eligible for and will forfeit any severance benefits or future equity vesting.

William (“Chip”) Dorsey, Vice President, Finance will serve as interim head of U.S. Operations and Global Diagnostics while the Company conducts a search for Mr. David's permanent replacement. Zoetis was recently made aware of allegations of a consensual personal relationship between Mr. David and a colleague that he did not disclose. Immediately upon learning of the allegations, the Company initiated an investigation and retained independent outside counsel to assist in this process.

Upon receiving the findings of the investigation, the Company moved quickly and terminated Mr. David. His conduct was inconsistent with Zoetis' values and policies, and it has no place at the Company.